Peiying Yang, Ph.D.

Peiying Yang, Ph.D., is a Principal Investigator at The University of Texas MD Anderson Cancer Center. Her research integrates cancer biology, pharmacology, and oncology, focusing on the molecular mechanisms of tumor invasion and metastasis, particularly in pancreatic and colorectal cancers. Recent work explores biofield therapy's modulation of metastatic cascades, the chemopreventive roles of lipoxygenases in colorectal tumorigenesis, and the development of dual-drug polymeric micelles (ONP-001) for pancreatic and hepatocellular carcinomas. She also investigates radiation oncology supportive care, including radioprotective agents and analgesic efficacy in cancer pain management. Her publications appear in leading journals such as *Cancer Research* and *Scientific Reports*.